For instance, Cop1 is amplified in certain human cancers such as hepatocellular carcinomas and breast cancer where p53 is not frequently mutated, suggesting an essential role of Cop1 in p53 inhibition in the context of these types of human cancers. Here, TP53 is linked to hepatocellular carcinoma.